Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bile acids are steroid acids synthesized in the liver from cholesterol, playing crucial roles in digestion, absorption of dietary fats, cholesterol excretion, and metabolic regulation. They act as detergents to emulsify fats, form micelles for nutrient absorption, and eliminate cholesterol through fecal excretion. Bile acids also exhibit antimicrobial activity, modulate the gut microbiome, and function as signaling molecules by activating nuclear receptors like FXR and membrane receptors like TGR5/GPBAR1. Disorders in bile acid metabolism can lead to various hepatic and systemic diseases. Ursodeoxycholic acid is a therapeutic bile acid used to treat primary biliary cirrhosis.
Ursodeoxycholic acid (UDCA) is used to treat primary biliary cirrhosis. Other bile acids and their derivatives might target FXR, TGR5/GPBAR1 receptors to modulate metabolism or used to dissolve gallstones.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile Acid.